Inflamatory Bowel DiseaseIBD-MSUSNCT07721844
Screening Questionnaires and Musculoskeletal Ultrasound for Early Detection of Spondyloarthritis in IBD Patients
An observational study of Inflamatory Bowel Disease and Spondylarthritis, run by Assiut University at 1 site in Egypt.
Trial summary
This study aims to evaluate the screening performance of the DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS) for the early detection of spondyloarthritis in patients previously diagnosed with Inflammatory Bowel Disease (IBD). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Inflamatory Bowel Disease, Spondylarthritis
- What is being tested?
- DETAIL .IBIS_Q . MSUS
- How many people
- 200 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Sep 2026to 1 Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients with inflammatory bowel disease (IBD) attending the gastroenterology and outpatient clinics at Assiut University Hospital, who will be sequentially screened for early detection of associated spondyloarthritis.
Who may be able to join
- Adult Aged 18 years old or more Confirmed diagnosis of IBD (by established clinical, endoscopic, and histopathological criteria).
- Patient provides informed written consent to participate
Who cannot join
- Known, pre-existing diagnosis of Spondyloarthritis or any other concomitant systemic autoimmune rheumatic disease.
- Severe secondary osteoarthritis or major joint trauma/surgery mimicking SpA. Cognitive impairment or communication barriers preventing comprehension or completion of questionnaires
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Assiut University Hospital
Asyut, Asyut Governorate, 71515
Shaimaa Salah Abdelaziz, MBBCH, 01093098451, shaima.17289546@med.aun.edu.eg
About this study
Official title: Incremental Value of Musculoskeletal Ultrasound After DETAIL and IBIS-Q Screening for Early Detection of IBD-associated Spondyloarthritis.
This study aims to evaluate the screening performance of the DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS) for the early detection of spondyloarthritis in patients previously diagnosed with Inflammatory Bowel Disease (IBD).
Read the detailed description
Inflammatory bowel disease (IBD) is frequently associated with extraintestinal manifestations, with spondyloarthritis (SpA) being the most common. Early detection is crucial to prevent structural damage. This prospective study will screen consecutive adult patients with IBD using the DETAIL and IBIS-Q questionnaires. Patients will then undergo a comprehensive clinical and musculoskeletal ultrasound (MSUS) assessment to evaluate the incremental diagnostic value of ultrasound in detecting early and subclinical SpA.
- Conditions
- Inflamatory Bowel Disease, Spondylarthritis
- Being tested
- DETAIL .IBIS_Q . MSUS
- Keywords
- DETAIL questionnaire, IBIS-Q questionnaire, Musculoskeletal ultrasound, Screening, IBD
- Medical subject headings
- Spondylarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DETAIL .IBIS_Q . MSUSDiagnostic test
All patients will be screened using the DETAIL and IBIS-Q questionnaires, followed by a comprehensive musculoskeletal ultrasound (MSUS) assessment.
| Study group | Role | What they receive |
|---|---|---|
| IBD Patients | consecutive adult patients diagnosed with Inflammatory Bowel Disease (IBD) who will undergo screening for early detection of spondyloarthritis. Receives: Diagnostic Test: DETAIL .IBIS_Q . MSUS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of undiagnosed spondyloarthritis
The percentage of patients with inflammatory bowel disease (IBD) who are newly diagnosed with spondyloarthritis based on DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS).
Measured: At the time of clinical evaluation (up to 12 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2026
- Study start1 Sep 2026 (estimated)
- Primary completion1 Sep 2027 (estimated)
- Study completion1 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Inflamatory Bowel DiseaseStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shaimaa Salah Abdelaziz Sayed, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07721844
- Sponsor's protocol ID
- Assiut-IBD-MSUS
- Acronym
- IBD-MSUS
- Status last verified
- Jul 2026
- First submitted
- 19 Jul 2026
- Last updated
- 23 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: To protect patient privacy and confidentiality.
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Incremental Value of Musculoskeletal Ultrasound After DETAIL and IBIS-Q Screening for Early Detection of IBD-associated Spondyloarthritis.
- ClinicalTrials.gov ID
- NCT07721844
- Acronym / sponsor ID
- IBD-MSUS / Assiut-IBD-MSUS
- Conditions
- Inflamatory Bowel Disease, Spondylarthritis
- Keywords
- DETAIL questionnaire, IBIS-Q questionnaire, Musculoskeletal ultrasound, Screening, IBD
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Sep 2026 (estimated)
- Primary completion
- 1 Sep 2027 (estimated)
- Study completion
- 1 Dec 2027 (estimated)
- First posted
- 23 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the screening performance of the DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS) for the early detection of spondyloarthritis in patients previously diagnosed with Inflammatory Bowel Disease (IBD).
Detailed description
Inflammatory bowel disease (IBD) is frequently associated with extraintestinal manifestations, with spondyloarthritis (SpA) being the most common. Early detection is crucial to prevent structural damage. This prospective study will screen consecutive adult patients with IBD using the DETAIL and IBIS-Q questionnaires. Patients will then undergo a comprehensive clinical and musculoskeletal ultrasound (MSUS) assessment to evaluate the incremental diagnostic value of ultrasound in detecting early and subclinical SpA.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| IBD Patients | – | Diagnostic Test: DETAIL .IBIS_Q . MSUSconsecutive adult patients diagnosed with Inflammatory Bowel Disease (IBD) who will undergo screening for early detection of spondyloarthritis. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients with inflammatory bowel disease (IBD) attending the gastroenterology and outpatient clinics at Assiut University Hospital, who will be sequentially screened for early detection of associated spondyloarthritis.
Key inclusion criteria (2 listed)
- Adult Aged 18 years old or more Confirmed diagnosis of IBD (by established clinical, endoscopic, and histopathological criteria).
- Patient provides informed written consent to participate
Key exclusion criteria (2 listed)
- Known, pre-existing diagnosis of Spondyloarthritis or any other concomitant systemic autoimmune rheumatic disease.
- Severe secondary osteoarthritis or major joint trauma/surgery mimicking SpA. Cognitive impairment or communication barriers preventing comprehension or completion of questionnaires
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DETAIL .IBIS_Q . MSUSAll patients will be screened using the DETAIL and IBIS-Q questionnaires, followed by a comprehensive musculoskeletal ultrasound (MSUS) assessment. | Diagnostic test | IBD Patients |
Primary outcome
Prevalence of undiagnosed spondyloarthritis
Time frame: At the time of clinical evaluation (up to 12 months)
The percentage of patients with inflammatory bowel disease (IBD) who are newly diagnosed with spondyloarthritis based on DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2026.
- Individual participant dataSharing planned: No. To protect patient privacy and confidentiality.
Related trials for Inflamatory Bowel Disease
Recruiting
Non-nutritive Sweeteners in Inflammatory Bowel Disease
Inflamatory Bowel Disease, Crohn Disease (CD)
Active, not recruiting
Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis), Inflamatory Bowel Disease
RecruitingObservational study
Inflammatory Bowel Disease (IBD) Research Registry
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
RecruitingObservational study
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
Inflamatory Bowel Disease, Crohn Disease (CD)
Recruiting
Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease
Inflamatory Bowel Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Inflamatory Bowel Disease and Spondylarthritis, run by Assiut University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 23 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Shaimaa Salah Abdelaziz, mbbch (01093098451, shaima.17289546@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of undiagnosed spondyloarthritis (time frame: At the time of clinical evaluation (up to 12 months)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2026.